The crosstalk between tissue engineering and pharmaceutical biotechnology: Recent advances and future directions

Current Pharmaceutical Biotechnology

Volumn 16, Issue 11, 2015, Pages 1012-1023

  Pacheco, Daniela P ^a   Reis, Rui L ^a   Correlo, Vítor M ^a   Marques, Alexandra P ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

3D tissue like models; Pharmaceutical biotechnology; Tissue engineering; Tissue engineered constructs

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CHEMICAL STRUCTURE; DRUG SCREENING; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; MRNA EXPRESSION ASSAY; NONHUMAN; PHARMACEUTICAL BIOTECHNOLOGY; PHARMACEUTICS; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; ANIMAL; BIOLOGICAL MODEL; CELL FUNCTION; PROCEDURES; TISSUE SCAFFOLD;

ANIMALS; BIOPHARMACEUTICS; BIOTECHNOLOGY; CELL PHYSIOLOGICAL PHENOMENA; HUMANS; MODELS, BIOLOGICAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84942108615     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201016666150826120257     Document Type: Article

References (142)

1. Frantz, C.; Stewart, K.M.; Weaver ,V.M. The extracellular matrix at a glance. J. Cell Sci., 2010, 123(24), 4195-4200.
2. Discher, D.E.; Janmey, P.; Wang, Y-L. Tissue cells feel and respond to the stiffness of their substrate. Science, 2005, 310(5751), 1139-1143.
3. Nelson, C.M.; Vanduijn, M.M.; Inman, J.L.; Fletcher, D.A.; Bissell, M.J. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science, 2006, 314(5797), 298-300.
4. Mori, H.; Gjorevski, N.; Inman, J.L.; Bissell, M.J.; Nelson, C.M. Self-organization of engineered epithelial tubules by differential cellular motility. Proc. Natl. Acad. Sci. USA, 2009, 106(35), 14890-14895.
5. Discher, D.E.; Mooney, D.J.; Zandstra, P.W. Growth factors, matrices, and forces combine and control stem cells. Science, 2009, 324(5935), 1673-1677.
6. Moore, K.A.; Lemischka, I.R. Stem cells and their niches. Science, 2006, 311(5769), 1880-1885.
7. Rennert, R.C.; Sorkin, M.; Garg, R.K.; Gurtner, G.C. Stem cell recruitment after injury: lessons for regenerative medicine. Regen. Med., 2012, 7(6), 833-850.
8. Perbal, B. Communication is the key. Cell Commun. Signal., 2003, 1(3), 1-4.
9. Barthes, J.; Ozcelik, H.; Hindie, M.; Ndreu-Halili, A.; Hasan, A.; Vrana, N.E. Cell Microenvironment engineering and monitoring for tissue engineering and regenerative medicine: the recent advances. Biomed. Res. Int., 2014, 2014, 921905.
10. Langer, R.; Vacanti, J.P. Tissue Engineering. Science, 1993, 260(5110), 920-926.
11. Dhandayuthapani, B.; Yoshida, Y.; Maekawa, T.; Kumar, D.S. Polymeric scaffolds in tissue engineering application: A review. Int. J. Polym. Sci., 2011, 2011, 290602.
12. Lutolf, M.P.; Hubbell, J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol., 2005, 23(1), 47-55.
13. Geckil, H.; Xu, F.; Zhang, X.; Moon, S.; Demirci, U. Engineering hydrogels as extracellular matrix mimics. Nanomedicine, 2010, 5(3): 469-484.
14. Chen, F.M.; Zhang, M.; Wu, Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials, 2010, 30, 6279-308.
15. OECD. Definition of Biotechnology. http://www.oecd.org/sti/biotech/ statisticaldefinitionofbiotechnology.html. (Accessed Jan 23; 2015).
16. Petrova, E. In: Innovation and Marketing in the Pharmaceutical Industry; Min Ding, Jehoshua Eliashberg, Stefan Stremersch, Eds.; Springer: New York, 2014, pp. 19-81.
17. Farajollahi, M.M.; Hamzehlou, S.; Mehdipour, A.; Samadikuchaksaraei, A. Recombinant proteins: hopes for tissue engineering. BioImpacts, 2012, 2(3), 123-125.
18. Blitterswijk, C.; Moroni, L.; Rouwkema, J.; Siddappa, R.; Sohier, J.; Blitterswijk, C.; Moroni, L.; Rouwkema, J.; Siddappa, R.; Sohier, J. In: Tissue Engineering; Clemens van Blitterswijk, Peter Thomsen, Anders Lindahl, Jeffrey Hubbell, David F. Williams, Ranieri Cancedda, Joost D. de Bruijn and Jerome Sohier, Eds.; Academic Press: USA, 2008, pp. xiii-xxxvi.
19. Vincent, J.F.V.; Bogatyreva, O.A.; Bogatyrev, N.R.; Bowyer, A.; Pahl, A-K. Biomimetics: Its practice and theory. J. R. Soc. Interface, 2006, 3(9), 471-482.
20. Antonietti, M.; Fratzl, P. Biomimetic principles in polymer and material science. Macromol. Chem. Phys., 2010, 211(2), 166-170.
21. Rodriguez-Cabello, J.C.; Martin, L.; Alonso, M.; Arias, F.J.; Testera, A.M. "Recombinamers" as advanced materials for the post-oil age. Polymer, 2009, 50(22), 5159-5169.
22. Gavanji, S. Application of recombinant DNA technology-A review. App. Sci. Report, 2013, 2(2), 29-31.
23. Reddi, A.H. Bone and cartilage differentiation. Curr. Opin. Genet. Dev., 1994, 4, 737-44.
24. Hubbell, J.A. Biomaterials in tissue engineering. Biotechnology, 1995, 13(6), 565-576.
25. Oner, E.T. In: Pretreatment Techniques for Biofuels and Biorefineries; Zhen Fhang, Ed.; Springer: Berlin, 2013, pp. 35-56.
26. Patterson, J.; Martino, M.M.; Hubbell, J.A. Biomimetic materials in tissue engineering. Mater. Today, 2010, 13(1-2), 14-22.
27. Parenteau-Bareil, R.; Gauvin, R.; Berthod, F. Collagen-based biomaterials for tissue engineering applications. Materials, 2010, 3(3), 1863-1887.
28. An, B.; Kaplan, D.L.; Brodsky, B. Engineered recombinant bacterial collagen as an alternative collagen-based biomaterial for tissue engineering. Front. Chem., 2014, 2(40), 1-5.
29. Olsen, D.; Yang, C.; Bodo, M.; Chang, R.; Leigh, S.; Baez, J.; Carmichaela, D.; Perala, M.; Hamalainenet E-R.; Jarvinenb, M.; Polarek, J. Recombinant collagen and gelatin for drug delivery. Adv. Drug Deliv. Rev., 2003, 55, 1547-1567.
30. Yang, C.; Hillas, P.J.; Baez, J.A.; Nokelainen, M.; Balan, J.; Tang. J.; Spiro, R.; Polarek, J.W. The application of recombinant human collagen in tissue engineering. Biodrugs, 2004, 18(2), 103-119.
31. Lin, Y.K.; Liu, D.C. Comparison of physical-chemical properties of type I collagen from different species. Food Chem., 2006, 99(2): 244-251.
32. Werkmeister, J.A.; Ramshaw, J.A.M. Recombinant protein scaffolds for tissue engineering. Biomed. Mater., 2012, 7, 012002.
33. Gosline, J.; Lillie, M.; Carrington, E.; Guerette, P.; Ortlepp, C.; Savage, K. Elastic proteins: biological roles and mechanical properties. Philos. Trans. R Soc. Lond. B Biol. Sci., 2002, 357(1418), 121-132.
34. Xiao, S.; Stacklies, W.; Cetinkaya, M.; Markert, B.; Grater, F. Mechanical response of silk crystalline units from forcedistribution analysis. Biophys. J., 2009, 96(10), 3997-4005.
35. Keten, S.; Xu, Z.; Ihle, B.; Buehler, M.J. Nanoconfinement controls stiffness, strength and mechanical toughness of beta-sheet crystals in silk. Nat. Mater., 2010, 9(4), 359-367.
36. Omenetto, F.G.; Kaplan, D.L. New opportunities for an ancient material. Science, 2010, 329(5991), 528-531.
37. Fahnestock, S.R.; Irwin, S.L. Synthetic spider dragline silk proteins and their production in Escherichia coli. Appl. Microbiol. Biotechnol., 1997, 47(1), 23-32.
38. Fahnestock, S.R.; Bedzyk, L.A. Production of synthetic spider dragline silk protein in Pichia pastoris. Appl. Microbiol. Biotechnol., 1997, 47(1), 33-39.
39. Lazaris, A.; Arcidiacono, S.; Huang, Y.; Zhou, J-F.; Duguay, F.; Chretien, N.; Welsh W.A.; Soares J.W.; Karatzas, C.N. Spider silk fibers spun from soluble recombinant silk produced in mammalian cells. Science, 2002, 295(5554), 472-476.
40. Scheller, J.; Guhrs, K.H.; Grosse, F.; Conrad, U. Production of spider silk proteins in tobacco and potato. Nat. Biotechnol., 2001, 19(6), 573-577.
41. Scheller, J.; Henggeler, D.; Viviani, A.; Conrad, U. Purification of spider silk-elastin from transgenic plants and application for human chondrocyte proliferation. Transgenic Res., 2004, 13(1), 51-57.
42. Wise, S.G.; Mithieux, S.M.; Raftery, M.J.; Weiss, A.S. Specificity in the coacervation of tropoelastin: Solvent exposed lysines. J. Struct. Biol., 2005, 149(3), 273-281.
43. Vrhovski, B.; Jensen, S.; Weiss, A.S. Coacervation characteristics of recombinant human tropoelastin. Eur. J. Biochem., 1997, 250(1), 92-98.
44. Bellingham, C.M.; Lillie, M.A.; Gosline, J.M.; Wright, G.M.; Starcher, B.C.; Bailey, A.J.; Woodhouse, K.A.; Keeley, F.W. Recombinant human elastin polypeptides self-assemble into biomaterials with elastin-like properties. Biopolymers, 2003, 70(4), 445-455.
45. Meyer, D.E.; Chilkoti, A. Genetically encoded synthesis of proteinbased polymers with precisely specified molecular weight and sequence by recursive directional ligation: Examples from the the elastin-like polypeptide system. Biomacromolecules, 2002, 3(2), 357-367.
46. Guda, C.; Lee, S-B.; Daniell, H. Stable expression of a biodegradable protein-based polymer in tobacco chloroplasts. Plant Cell Reports, 2000, 19, 257-262.
47. Sallach, R.E.; Conticello, V.P.; Chaikof, E.L. Expression of a recombinant elastin-like protein in Pichia pastoris. Biotechnol. Prog., 2009, 25(6), 1810-1818.
48. Tjin, M.S.; Low, P.; Fong, E. Recombinant elastomeric protein biopolymers: progress and prospects. Polym. J., 2014, 46(8), 444-451.
49. Altman, G.H.; Diaz, F.; Jakuba, C.; Calabro, T.; Horan, R.L.; Chen, J.; Lu, H.; Richmond, J.; Kaplan, D.L. Silk-based biomaterials. Biomaterials, 2003, 24(3), 401-416.
50. Urry, D.W.; Urry, K.D.; Szaflarski, W.; Nowicki, M. Elasticcontractile model proteins: Physical chemistry, protein function and drug design and delivery. Adv. Drug Deliv. Rev., 2010, 62, 1404-1455.
51. Wang, X.; Xu, P.; Yuan, Y.; Liu, C.; Zhang, D.; Yang, Z.; Yang, C.; Ma, C. Modeling for gellan gum production by Sphingomonas paucimobilis ATCC 31461 in a simplified medium. Appl. Environ. Microbiol., 2006, 72(5), 3367-3374.
52. Ruoslahti, E. Proteoglycans in cell regulation. J. Biol. Chem., 1989, 264(23), 13369-133672.
53. Jen, A.C.; Wake, M.C.; Mikos, A.G. Review: Hydrogels for cell immobilization. Biotechnol. Bioeng., 1996, 50, 357-64.
54. Oliveira, J.T.; Santos, T.C.; Martins, L.; Picciochi, R.; Marques, A.P.; Castro, A.G.; Neves, N.M.; Mano, J.F.; Reis, R.L. Gellan gum injectable hydrogels for cartilage tissue engineering applications: in vitro studies and preliminary in vivo evaluation. Tissue Eng. Part A, 2010, 16(1), 343-353.
55. Silva-Correia, J.; Oliveira, J.M.; Caridade, S.G.; Oliveira, J.T.; Sousa, R.A.; Mano, J.F., Reis, R.L. Gellan gum-based hydrogels for intervertebral disc tissue-engineering applications. J. Tissue Eng. Regen. Med., 2011, 5(6), 524-531.
56. Cerqueira, M.T.; da Silva, L.P.; Santos, T.C.; Pirraco, R.P.; Correlo, V.M.; Marques, A.P.; Reis, R.L. Human skin cell fractions fail to self-organize within a gellan gum/hyaluronic acid matrix but positively influence early wound healing. Tissue Eng. Part A, 2014, 20(9-10), 1369-1378.
57. Cerqueira, M.T.; da Silva, L.P.; Santos, T.C.; Pirraco, R.P.; Correlo, V.M.; Reis, R.L.; Marques, A.P. Gellan gum-hyaluronic acid spongy-like hydrogels and cells from adipose tissue synergize promoting neoskin vascularization. ACS Appl. Mater. Interfaces, 2014, 6(22), 19668-19679.
58. Gantar, A.; da Silva, L.P.; Oliveira, J.M.; Marques, A.P.; Correlo, V.M.; Novak, S.; Reis, R.L. Nanoparticulate bioactive-glassreinforced gellan-gum hydrogels for bone-tissue engineering. Mater. Sci. Eng. C, 2014, 43, 27-36.
59. Centeno-Leija, S.; Huerta-Beristain, G.; Giles-Gomez, M.; Bolivar, F.; Gosset, G.; Martinez, A. Improving poly-3-hydroxybutyrate production in Escherichia coli by combining the increase in the NADPH pool and acetyl-CoA availability. Int. J. Gen. Mol. Microbiol., 2014, 105(4), 687-696.
60. Chen, G.Q.; Wu, Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials, 2005, 26, 6565-6578.
61. Pena, C.; Castillo, T.; Garcia, A.; Millan, M.; Segura, D. Biotechnological strategies to improve production of microbial poly-(3-hydroxybutyrate): A review of recent research work. Microbial. Biotechnol., 2014, 7(4), 278-293.
62. Shamos, M.H.; Lavine, L.S. Piezoelectricity as a fundamental property of biological tissues. Nature, 1967, 213(5073), 267-269.
63. Miller, N.D.; Williams, D.F. On the biodegradation of poly-β-hydroxybutyrate (PHB) homopolymer and poly-β-hydroxybutyratehydroxyvalerate copolymers. Biomaterials, 1987, 8, 129-137.
64. Peppas, N.A.; Hilt, J.Z.; Khademhosseini, A.; Langer, R. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv. Mat., 2006, 18, 1345-1360.
65. Tibbitt, M.W.; Anseth, K.S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol. Bioeng., 2009, 103(4), 655-663.
66. Pulkkinen, H.J.; Tiitu, V.; Valonen, P.; Hamalainen, E.R.; Lammi, M.J.; Kiviranta, I. Recombinant human type II collagen as a material for cartilage tissue engineering. Int. J. Artif. Organs, 2008, 31(11), 2008.
67. Pulkkinen, H.J.; Tiitu, V.; Valonen, P.; Jurvelin, J.S.; Lammi, M.J.; Kiviranta, I. Engineering of cartilage in recombinant human type II collagen gel in nude mouse model in vivo. Osteoarthr Cartil., 2010, 18(8), 1077-1087.
68. Haider, M.; Cappello, J.; Ghandehari, H.; Leong, K.W. In vitro chondrogenesis of mesenchymal stem cells in recombinant silkelastinlike hydrogels. Pharm. Res., 2008, 25(3), 692-699.
69. Oliveira, J.T.; Santos, T.C.; Martins, L.; Silva, M.A.; Marques, A.P.; Castro, A.G.; Neves, N.M.; Reis, R.L. Performance of new gellan gum hydrogels combined with human articular chondrocytes for cartilage regeneration when subcutaneously implanted in nude mice. J. Tissue Eng. Regen. Med., 2009, 3(7), 493-500.
70. Oliveira, J.T.; Gardel, L.S.; Rada, T.; Martins, L.; Gomes, M.E.; Reis, R.L. Injectable gellan gum hydrogels with autologous cells for the treatment of rabbit articular cartilage defects. J. Orthop. Res., 2010, 28(9), 1193-1199.
71. da Silva, L.P.; Cerqueira, M.T.; Sousa, R.A.; Reis, R.L.; Correlo, V.M.; Marques, A.P. Engineering cell-adhesive gellan gum spongy-like hydrogels for regenerative medicine purposes. Acta Biomater., 2014, 10(11), 4787-4797.
72. Abrams, G.A.; Goodman, S.L.; Nealey, P.F.; Franco, M.; Murphy, C.J. Nanoscale topography of the basement membrane underlying the corneal epithelium of the rhesus macaque. Cell Tissue Res., 2000, 299(1), 39-46.
73. Wang, X.; Ding, B.; Li, B. Biomimetic electrospun nanofibrous structures for tissue engineering. Mater. Today, 2013, 16(6), 229-241.
74. Zonari, A.; Novikoff, S.; Electo, N.R.P.; Breyner, N.M.; Gomes, D.A.; Martins, A.; Neves, N.M.; Reis, R.L.; Goes, A.M. Endothelial differentiation of human stem cells seeded onto electrospun polyhydroxybutyrate/polyhydroxybutyrate-co-hydroxyvalerate fiber mesh. PLoS One, 2012, 7(4), e35422.
75. Masaeli, E.; Morshed, M.; Nasr-Esfahani, M.H.; Sadri, S.; Hilderink, J.; van Apeldoorn, A.; van Blitterswijk, C.A.; Moroni, L. Fabrication, characterization and cellular compatibility of poly(hydroxy alkanoate) composite nanofibrous scaffolds for nerve tissue engineering. PLoS One, 2013, 8(2), 16-18.
76. Zonari, A.; Cerqueira, M.T.; Novikoff, S.; Goes, A.M.; Marques, A.P.; Correlo, V.M.; Reis R.L. Poly(hydroxybutyrate-cohydroxyvalerate) bilayer skin tissue engineering constructs with improved epidermal rearrangement. Macromol. Biosci., 2014, 14(7), 977-990.
77. Dudognon, B.; Romero-Santacreu, L.; Gomez-Sebastian, S.; Hidalgo, A.B.; Lopez-Vidal, J.; Bellido, M.L.; Munoz, E.; Escribano, J.M. Production of functional active human growth factors in insects used as living biofactories. J. Biotechnol., 2014, 184, 229-239.
78. Simons, M.; Annexm, B.H.; Laham, R.J.; Kleiman, N.; Henry, T.; Dauerman, H.; Udelson, J.E.; Gervino E.V.; Pike, M.; Whitehouse, M.J.; Moon, T.; Chronos, N.A. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation, 2002, 105(7), 788-793.
79. Fernandez-Montequin, J.I.; Infante-Cristia, E.; Valenzuela-Silva, C.; Franco-Perez, N.; Savigne-Gutierrez, W.; Artaza-Sanz. H.; Morejon-Vega, L.; Gonzalez-Benavides, C.; Eliseo-Musenden, O.; Garcia-Iglesias, E.; Berlanga-Acosta, J.; Silva-Rodriguez, R.; Betancourt, B.Y.; Lopez-Saura, P.A. Intralesional injections of Citoprot-PR (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation. Int. Wound J., 2007, 4(4), 333-343.
80. Kitamura, M.; Nakashima, K.; Kowashi. Y.; Fujii, T.; Shimauchi, H.; Sasano, T.; Furuuchi, T.; Fukuda, M.; Noguchi, T.; Shibutani, T.; Iwayama, Y.; Takashiba, S.; Kurihara, H.; Ninomiya, M.; Kido, J.; Nagata, T.; Hamachi, T.; Maeda, K.; Hara, Y.; Izumi, Y.; Hirofuji, T.; Imai, E.; Omae, M.; Watanuki, M.; Murakami, S. Periodontal tissue regeneration using fibroblast growth factor-2: Randomized controlled phase II clinical trial. PLoS One, 2008, 3(7), 1-11.
81. Spiller, K.L.; Vunjak-Novakovic, G. Clinical translation of controlled protein delivery systems for tissue engineering. Drug Deliv Transl Res., 2013, 5(2), 101-115.
82. FDA. Approval letter for INFUSE bone graft-P000054. 2004.
83. FDA. Approval letter of INFUSE bone graft-P050053. 2007.
84. FDA. Approval letter for OP-1 Implant-H010002. 2001.
85. Fang, R.C.; Galiano, R.D. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics, 2008, 2(1), 1-12.
86. Lee, K.; Silva, E.A.; Mooney, D.J. Growth factor delivery-based tissue engineering: General approaches and a review of recent developments. J. R. Soc. Interface, 2011, 8(55), 153-170.
87. Florczyk, S.J.; Leung, M.; Jana, S.; Li, Z.; Bhattarai, N.; Huang, J.I.; Hopper, R.A.; Zhang, M. Enhanced bone tissue formation by alginate gel-assisted cell seeding in porous ceramic scaffolds and sustained release of growth factor. J. Biomed. Mater. Res. -Part A, 2012, 100(12), 3408-3415.
88. Manning, C.N.; Schwartz, A.G.; Liu, W.; Xie, J.; Havlioglu, N.; Sakiyama-Elbert, S.E.; Silva, M.J.; Xia, Y.; Gelberman, R.H.; Rhomopoulos, S. Controlled delivery of mesenchymal stem cells and growth factors using a nanofiber scaffold for tendon repair. Acta Biomater., 2013, 9(6), 6905-6914.
89. Sridhar, B.V.; Brock, J.L.; Silver, J.S.; Leight, J.L.; Randolph, M.A.; Anseth, K.S. Development of a cellularly degradable PEG hydrogel to promote articular cartilage extracellular matrix deposition. Adv. Healthc. Mater., 2015.
90. Christ, G.J.; Saul, J.M.; Furth, M.E.; Andersson, K. The pharmacology of regenerative medicine. Pharmacol. Rev., 2013, 65(3), 1091-1133.
91. Guo, X.; Liao, J.; Park, H.; Saraf, A.; Raphael, R.M.; Tabata, Y.; Kasper, F.K.; Mikos, A.G. Effects of TGF-β3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater., 2010, 6(8), 2920-2931.
92. Bian, L.; Zhai, D.Y.; Tous, E.; Rai, R.; Mauck, R.L.; Burdick, J.A. Enhanced MSC chondrogenesis following delivery of TGF-β3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. Biomaterials, 2011, 32(27), 6425-6434.
93. Diaz-Herraez, P.; Garbayo, E.; Simon-Yarza, T.; Formiga, F.R.; Prosper, F.; Blanco-Prieto, M.J. Adipose-derived stem cells combined with neuregulin-1 delivery systems for heart tissue engineering. Eur. J. Pharm. Biopharm., 2013, 85(1), 143-150.
94. Jay, S.M.; Shepherd, B.R.; Andrejecsk, J.W.; Kyriakides, T.R.; Pober, J.S.; Saltzman, W.M. Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization. Biomaterials, 2010, 31(11), 3054-3062.
95. Johnson, P.J.; Parker, S.R.; Sakiyama-Elbert, S.E. Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng., 2009, 104(6), 1207-1214.
96. Johnson, P.J.; Tatara, A.; Shiu, A.; Sakiyama-Elbert, S.E. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant., 2010, 19(1), 89-101.
97. Shah, N.J.; Macdonald, M.L.; Beben, Y.M.; Padera, R.F.; Samuel, R.E.; Hammond, P.T. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials, 2011, 32(26), 6183-6193.
98. Russell, S.J. Science, medicine, and the future: Gene therapy. BMJ, 1997, 315, 1289-1292.
99. Saraf, A.; Mikos, A.G. Gene delivery strategies for cartilage tissue engineering. Adv. Drug Deliv. Rev., 2006, 58, 592-603.
100. Klefenz, H. In: Industrial pharmaceutical biotechnology; Heinrich Klefenz, Ed.; Wiley-VCH Verlag GmbH: Germany, 2002, pp. 1-60.
101. Santos, J.L.; Pandita, D.; Rodrigues, J.; Pego, A.P.; Granja, P.L.; Tomas, H. Non-viral gene delivery to mesenchymal stem cells: Methods, strategies and application in bone tissue engineering and regeneration. Curr. Gene Ther., 2011, 11(1), 46-57.
102. Yang, Y.; Jin, G.; Li, L.; Liu, X.; Lo, C.; Wu, J. Enhanced osteogenic activity of mesenchymal stem cells and co-modified BMP-2 and bFGF genes. Ann Transplant., 2014, 19, 629-638.
103. Devalliere, J.; Chang, W.G.; Andrejecsk, J.W.; Abrahimi, P.; Cheng, C.J.; Jane-Wit, D.; Saltzaman, W.M.; Pober, J.S. Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation. FASEB J., 2014, 28(2), 908-922.
104. Fang, Y.; Chen, X.; Godbey, W.T. Gene delivery in tissue engineering and regenerative medicine. J. Biomed. Mater. Res. Part B Appl. Biomater., 2014.
105. De Laporte, L.; Shea, L.D. Matrices and scaffolds for DNA delivery in tissue engineering. Adv. Drug Deliv. Rev., 2007, 59, 292-307.
106. Bengali, Z.; Shea, L.D. Gene delivery by immobilization to celladhesive substrates. MRS Bullet., 2005, 30(9), 659-662.
107. Rujitanaroj, P.O.; Jao, B.; Yang, J.; Wang, F.; Anderson, J.M.; Wang, J.; Chew, S.Y. Controlling fibrous capsule formation through long-term down-regulation of collagen type i (COL1A1) expression by nanofiber-mediated siRNA gene silencing. Acta Biomater., 2013, 9(1), 4513-4524.
108. Liu, X.; Ma, L.; Liang, J.; Zhang, B.; Teng, J.; Gao, C. RNAi functionalized collagen-chitosan/silicone membrane bilayer dermal equivalent for full-thickness skin regeneration with inhibited scarring. Biomaterials, 2013, 34(8), 2038-2048.
109. Krebs, M.D.; Salter, E.; Chen, E.; Sutter, K.A.; Alsberg, E. Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. J. Biomed. Mater. Res. -Part A, 2010, 92(3), 1131-1138.
110. Lee, J.S.; Lee, J.M.; Im, G-I. Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogenesis of adipose stem cells. Biomaterials, 2011, 32(3), 760-768.
111. Kraljevic, S.; Stambrook, P.J.; Pavelic, K. Accelerating drug discovery. Lancet, 2014, 383(9917), 575.
112. Mullard, A. New drugs cost US$2.6 billion to develop. Nat. Rev. Drug Discov., 2014, 13(12), 877.
113. Keseru, G.M.; Makara, G.M.The influence of lead discovery strategies on the properties of drug candidates. Nat. Rev. Drug Discov., 2009, 8 (3), 203-212.
114. Kang, L.; Chung, B.G.; Langer, R.; Khademhosseini, A. Microfluidics for drug discovery and development: from target selection to product lifecycle management. Drug Discov. Today, 2008, 13(1-2), 1-13.
115. Castel, D.; Pitaval, A.; Debily, M.A.; Gidrol, X. Cell microarrays in drug discovery. Drug Discov. Today, 2006, 11(13-14), 616-622.
116. Wang Z, Kim M-C, Marquez M, Thorsen T. High-density microfluidic arrays for cell cytotoxicity analysis. Lab Chip, 2007, 7, 740-745.
117. Lee, P.J.; Hung, P.J.; Lee, L.P. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol. Bioeng., 2007, 97(5), 1340-1346.
118. Gao, D.; Li, H.; Wang, N.; Lin, J. Evaluation of the absorption of methotrexate on cells and its cytotoxicity assay by using an integrated microfluidic device coupled to a mass spectrometer. Anal. Chem., 2012, 84(21), 9230-9237.
119. Ankam, S.; Teo, B.K.; Kukumberg, M.; Yim, E.K. High throughput screening to investigate the interaction of stem cells with their extracellular microenvironment. Organogenesis, 2013, 9(3), 128-142.
120. Viravaidya, K.; Sin, A.; Shuler, M.L. Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol. Prog., 2004, 20(1), 316-323.
121. Mahler, G.J.; Esch, M.B.; Glahn, R.P.; Shuler, M.L. Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity. Biotechnol. Bioeng., 2009, 104(1), 193-205.
122. Tatosian, D.A., Shuler, M.L. A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers. Biotechnol. Bioeng., 2009, 103(1), 187-198.
123. Kim, J.; Taylor, D.; Agrawal, N.; Wang, H.; Kim, H.; Han, A.; Rege, K.; Jayaraman, A. A programmable microfluidic cell array for combinatorial drug screening. Lab Chip, 2012, 12, 1813-1822.
124. Zhang, Y.; Zhang, W.; Qin, L. Mesenchymal-mode migration assay and antimetastatic drug screening with high-throughput microfluidic channel networks. Angew Chemie., 2014, 53(9), 2344-2348.
125. Faley, S.L.; Copland, M.; Wlodkowic, D.; Kolch, W.; Seale, K.T.; Wikswo, J.P.; Cooper, J.M. Microfluidic single cell arrays to interrogate signalling dynamics of individual, patient-derived hematopoietic stem cells. Lab Chip, 2009, 9(18), 2659-2664.
126. Shamir E.R.; Ewald A.J. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat. Rev. Mol. Cell Biol., 2014, 15(10), 647-664.
127. Pampaloni F.; Reynaud E.G.; Stelzer E.H.K. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol., 2007, 8(10), 839-845.
128. Lin, S-L.; Kisseleva, T.; Brenner, D.A.; Duffield, J.S. Pericytes and perivascular fibroblasts are the primary source of collagenproducing cells in obstructive fibrosis of the kidney. Am J Pathol., 2008, 173(6), 1617-1627.
129. Mehta, G.; Hsiao, A.Y.; Ingram, M.; Luker, G.D.; Takayama, S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J. Control. Release, 2012, 164(2), 192-204.
130. Li, Q.; Chen, C.; Kapadia, A.; Zhou, Q.; Harper, M.K.; Schaack, J.; Labarbera, D.V. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen. J. Biomol. Screen., 2011, 16(2), 141-154.
131. Tung, Y-C.; Hsiao, A.Y.; Allen, S.G.; Torisawa, Y.; Ho, M.; Takayama, S. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst, 2011, 136(3), 473-478.
132. Xu, Z.; Gao, Y.; Hao, Y.; Li, E.; Wang, Y.; Zhang, J.; Wang, W.; Gao, Z.; Wang, Q. Application of a microfluidic chip-based 3D coculture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials, 2013, 34(16), 4109-4117.
133. Patra, B.; Peng, Y-S.; Peng, C-C.; Liao, W-H.; Chen, Y-A.; Lin, KH.; Tung, Y-C.; Lee, C-H. Migration and vascular lumen formation of endothelial cells in cancer cell spheroids of various sizes. Biomicrofluidics, 2014, 8(5), 052109.
134. Ivascu, A.; Kubbies, M. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J. Biomol. Screen., 2006, 11(8), 922-932.
135. Justice, B.A.; Badr, N.A.; Felder, R.A. 3D cell culture opens new dimensions in cell-based assays. Drug Discov. Today, 2009, 14(1-2), 102-107.
136. Zhang, C.; Zhao, Z.; Abdul Rahim, N.A.; van Noort, D.; Yu, H. Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. Lab Chip, 2009, 9(22), 3185-3192.
137. Huh, D.; Hamilton, G.A.; Ingber, D.E. From 3D cell culture to organs-on-chips. Trends Cell Biol., 2011, 21(12), 745-754.
138. van der Meer, A.D.; van den Berg, A. Organs-on-chips: breaking the in vitro impasse. Integr Biol., 2012, 4, 461-470.
139. Ghaemmaghami, A.M.; Hancock, M.J.; Harrington, H.; Kaji, H.; Khademhosseini, A. Biomimetic tissues on a chip for drug discovery. Drug Discov. Today, 2012, 17(2-4), 173-181.
140. Huh, D.; Torisawa, Y.; Hamilton, G.A.; Kim, H.J.; Ingber, D.E. Microengineered physiological biomimicry: Organs-on-chips. Lab Chip, 2012, 12, 2156-2164.
141. Meli, L.; Barbosa, H.S.C.; Hickey, A.M.; Gasimli, L.; Nierode. G.; Diogo, M.M.; Linhardt, R.J.; Cabral, J.M.S.; Dordick, J.S. Three dimensional cellular microarray platform for human neural stem cell differentiation and toxicology. Stem Cell Res., 2014, 13(1), 36-47.
142. Boudou, T.; Legant, W.R.; Mu, A.; Borochin, M.A.; Thavandiran, N.; Radisic, M.; Zandstra, P.W.; Epstein, J.A.; Margulies, K.B.; Chen, C.S. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Engin. Part A, 2012, 18(9-10), 910-919.